NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 13 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55 | +61.8% | 60,150 | 0.0% | 0.01% | +66.7% |
Q2 2023 | $34 | -10.5% | 60,150 | 0.0% | 0.01% | -14.3% |
Q1 2023 | $38 | -19.1% | 60,150 | 0.0% | 0.01% | -22.2% |
Q4 2022 | $47 | -99.9% | 60,150 | +9.1% | 0.01% | +12.5% |
Q3 2022 | $39,000 | +11.4% | 55,150 | 0.0% | 0.01% | +14.3% |
Q2 2022 | $35,000 | +12.9% | 55,150 | +22.1% | 0.01% | +16.7% |
Q1 2022 | $31,000 | -3.1% | 45,150 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $32,000 | -44.8% | 45,150 | 0.0% | 0.01% | -46.2% |
Q3 2021 | $58,000 | -12.1% | 45,150 | 0.0% | 0.01% | -13.3% |
Q2 2021 | $66,000 | 0.0% | 45,150 | +1.5% | 0.02% | -6.2% |
Q1 2021 | $66,000 | -2.9% | 44,500 | 0.0% | 0.02% | -5.9% |
Q4 2020 | $68,000 | +257.9% | 44,500 | +78.0% | 0.02% | +183.3% |
Q3 2020 | $19,000 | +533.3% | 25,000 | +150.0% | 0.01% | +500.0% |
Q2 2020 | $3,000 | +50.0% | 10,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $2,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $2,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $2,000 | -33.3% | 10,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $3,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Moloney Securities Asset Management, LLC | 352,660 | $320,815 | 0.06% |
Opus Capital Group, LLC | 60,150 | $55 | 0.01% |
AlphaMark Advisors, LLC | 14,007 | $13 | 0.01% |
ADVISORS MANAGEMENT GROUP INC /ADV | 10,270 | $9 | 0.00% |
LEE DANNER & BASS INC | 20,000 | $18 | 0.00% |
Williams Jones Wealth Management, LLC. | 44,000 | $40,027 | 0.00% |
MAI Capital Management | 20,000 | $18,194 | 0.00% |
Bartlett & Co. LLC | 4,292 | $4 | 0.00% |
Coston, McIsaac & Partners | 1,000 | $0 | 0.00% |